Oral Sphere
Journal of Dental and Health Sciences
Journal of Dental and Health Sciences
Received: 2025-09-17
Accepted: 2025-12-30
Published: 2026-01-01
Pages: 41-46
The worldwide increase in the prevalence of obesity marks the beginning of the global public health crisis that it unparalleled in human history. Obesity is the second major public health problem after tobacco use. Obesity is the central problem underlying the other epidemics of chronic diseases such as cardiovascular diseases, type 2 diabetes, and non-alcoholic fatty liver disease. Obesity is the key underlying problem. The systemic and chronic inflammation fuels the associated co-morbid conditions and obesity itself. I will devote the remainder of this review to the mechanistic aspects of the systemic inflammation induced by obesity. I will begin with the primary source: the adipose tissue itself, and expansion of the fat tissue, and infiltrating immune cells, along with the various forms of insulin resistance. Then I will review the evidence of the adipocytes' secretion of pro-inflammatory and inflammation perpetuating cytokines and adipokines as the central activators of the chronic and systemic fuel to the metabolic dysfunction of inflammation. The exit of the obesity and inflammation cycle needs a management plan. The lifestyle changes targeting diet and physical activity focus on the inflammation axis and assist in fat mass decline, along with the use of some prescribed anti-inflammatory medications, and drugs such as GLP-1 agonists and SGLT-2 inhibitors. For patients with severe morbid obesity, the impact of immune-modulating fat mass reduction and bariatric surgery and gastric bypass is chronic and systemic. This review highlights the importance of integrating lifestyle modifications, medications, and surgical options in the management of obesity and inflammation to optimize health outcomes and mitigate the complications associated obesity.
1. Abad-Jiménez Z et al. Biomedicines. 2025 Feb 18;13(2):502. [DOI: 10.3390/biomedicines13020502]
2. Busebee B et al. Mayo Clin Proc. 2023 Dec;98(12):1842-1857. [DOI: 10.1016/j.mayocp.2023.05.026].
3. de Heredia FP et al. Proc Nutr Soc. 2012 May;71(2):332-8. [DOI: 10.1017/S0029665112000092]
4. Kawai T et al. Am J Physiol Cell Physiol. 2021 Mar 1;320(3):C375-C391. [DOI: 10.1152/ajpcell.00379.2020]
5. Park YM et al. Mo Med. 2014 Jan-Feb;111(1):65-72. [PMID: 24645302]
6. Savulescu-Fiedler et al. Life 2024, 14, 856. [DOI: 10.3390/life14070856]
7. Saijo Y et al. Diabetes Obes Metab. 2004 Jul;6(4):249-58. [DOI: 10.1111/j.1462-8902.2003.0342.x]
8. Ye J. Int J Obes (Lond). 2009 Jan;33(1):54-66. [DOI: 10.1038/ijo.2008.229]
9. Zatterale F et al. Front Physiol. 2020 Jan 29;10:1607. [DOI: 10.3389/fphys.2019.01607]
10. Kwon H et al. Front Endocrinol (Lausanne). 2013 Jun 12;4:71. [DOI: 10.3389/fendo.2013.00071]
11. Powell-Wiley TM et al. Circulation. 2021 May 25;143(21):e984-e1010. [DOI: 10.1161/CIR.0000000000000973]
12. Benedict M et al. World J Hepatol. 2017 Jun 8;9(16):715-732. [DOI: 10.4254/wjh.v9.i16.715]
13. Kong Y et al. Mol Biomed. 2025 Apr 25;6(1):25. [DOI: 10.1186/s43556-025-00264-9]
14. Freitas WR Jr et al. Obes Surg. 2018 Jul;28(7):1931-1942. [DOI:10.1007/s11695-017-3104-9]
15. Ghigliotti G et al. Inflammation. 2014 Aug;37(4):1337-53. [DOI:10.1007/s10753-014-9914-1]
16. Fuster JJ et al. Circ Res. 2016 May 27;118(11):1786-807. [DOI: 10.1161/CIRCRESAHA.115.306885]
17. Romeo GR et al. Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1771-6. [DOI: 10.1161/ATVBAHA.111.241869]
18. Henein MY et al. Int J Mol Sci. 2022 Oct 26;23(21):12906. [DOI: 10.3390/ijms232112906]
19. Tsalamandris S et al. Eur Cardiol. 2019 Apr;14(1):50-59. [DOI: 10.15420/ecr.2018.33.1]
20. Brunner KT et al. Curr Obes Rep. 2019 Sep;8(3):220-228. [DOI: 10.1007/s13679-019-00345-1]
21. Sears B et al. Front Nutr. 2021 Aug 10;8:709435. [DOI: 10.3389/fnut.2021.709435]
22. Kolb H. BMC Med 20, 494 (2022). [DOI: 10.1186/s12916-022-02672-y]
23. Shih KC et al. BMC Pediatr. 2018 Feb 22;18(1):80. [DOI: 10.1186/s12887-018-1025-y]
24. Atakan MM et al. Nutrients. 2021 Apr 25;13(5):1459. [DOI: 10.3390/nu13051459]
25. Ullah MI et al. Medicines (Basel). 2025 Jul 28;12(3):19. [DOI: 10.3390/medicines12030019]
26. Kim, J.W et al. Biomedicines 2024, 12, 97. [DOI: 10.3390/biomedicines12010097]
27. Reiss AB et al. Biomolecules. 2025 Mar 13;15(3):408. [DOI: 10.3390/biom15030408]
28. Popoviciu MS et al. Medicina (Kaunas). 2025 Mar 20;61(3):548. [DOI: 10.3390/medicina61030548]
29. Wolfe BM et al. Circ Res. 2016 May 27;118(11):1844-55. [DOI: 10.1161/CIRCRESAHA.116.307591]
30. Zhang H et al. Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2063-9. [DOI: 10.1161/ATVBAHA.111.225870]
31. Balistreri CR et al. Mediators Inflamm. 2010;2010:802078. [DOI: 10.1155/2010/802078]
